选择性雌激素受体调节剂（SERMs）是否是 HPV 相关宫颈病变和癌症的治疗选择？
Are selective estrogen receptor modulators (SERMs) a therapeutic option for HPV-associated cervical lesions and cancers?
机构信息
Division of Infectious Diseases, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
出版信息
Am J Pathol. 2014 Feb;184(2):358-61. doi: 10.1016/j.ajpath.2013.11.005. Epub 2013 Dec 15.
PMID:24345353
Abstract
This Commentary highlights the article by Spurgeon et al which evaluates oral SERM raloxifene as a potential therapeutic agent for HPV-associated cancer.
摘要
本述评强调了 Spurgeon 等人的文章，该文章评估了口服选择性雌激素受体调节剂雷洛昔芬作为 HPV 相关癌症的潜在治疗药物。
Zotero 插件